Catastrophic Antiphospholipid Syndrome in Obstetric Practice

Cover Page


Cite item

Full Text

Abstract

Catastrophic antiphospholipid syndrome (CAPS) is an uncommon, often fatal, form of the antiphospholipid syndrome that results in a widespread coagulopathy and affects predominantly small vessels supplying organs with the development of multiorgan failure against a background of high level of antiphospholipid antibodies. Thrombotic microvasculopathy is the basis of multiorgan failure and clinically manifests with CNS disturbances, adrenal failure, and the development of acute respiratory distress syndrome. CAPS is a life-threatening condition and requires urgent measures. Optimal treatment for CAPS is not developed yet. CAPS present a multidisciplinary problem. Authors demonstrate 17 cases of CAPS in patients which were managed from 2001 to 2012 years. Molecular mechanisms of pathogenesis and different obstetric and non-obstetric manifestations of CAPS are discussed in the article. There is the description of first case of management of pregnancy and labor of patient with CAPS in her history. The methods of CAPS prevention are described

About the authors

Alexander D Makatsariya

First Moscow State Medical University

Email: gemostasis@mail.ru
MD, PhD Professor, Correspondent Member of the RAMS, Head of the Chair of Obstetrics and Gynecology of Medical Prophylaxis Faculty, Vice-President of Russian Association of Obstetricians and Gynaecologists

Viktoriya O Bitsadze

I. M. Sechenov First Moscow State Medical University

Email: gemostasis@mail.ru
MD, PhD Professor of the Chair of Obstetrics and Gynecology of Medical Prophylaxis Faculty

Dzhamilya Kh Khizroeva

I. M. Sechenov First Moscow State Medical University

Email: gemostasis@mail.ru
MD, PhD, assistant of the Chair of Obstetrics and Gynecology of Medical Prophylaxis Faculty

References

  1. Антифосфолипидный синдром — иммунная тромбофилия в акушерстве и гинекологии / Макацария А. Д. [и др.]. — М.: Триада-Х, 2007. — 456 с.
  2. Баркаган З. С., Момот А. П., Сердюк Г. В. Основы диагностики и терапии антифосфолипидного синдрома. — М.: Ньюдиамед, 2003. — 48 с.
  3. Долгушина Н. В., Макацария А. Д. Вирусные инфекции у беременных: руководство для врачей. — М.:Триада-Х, 2004. — 144 с.
  4. Насонов Е. Л. Антифосфолипидный синдром. — М.: Литера, 2004. — 440 с.
  5. Насонов Е. Л. Современные подходы к профилактике и лечению антифосфолипидного синдрома // Терапевтический архив. — 2003. — № 5. — С. 83–87.
  6. Хизроева Д. Х. Антифосфолипидные антитела и тромботический шторм // Материалы XIII Всероссийского научного форума «Мать и Дитя». — М., 2011. — С. 213–214.
  7. Acute respiratory failure associated with catastrophic antiphospholipid syndrome / Wiedermann F. J. [et al.] // J. Intern. Med. — 2000. — Vol. 247. — P. 723–730.
  8. Asherson R. A. Multiorgan failure and antiphospholipid antibodies: the catastrophic antiphospholipid (Asherson's) syndrome // Immunobiology. — 2005. — Vol. 210. — P. 727–733.
  9. Asherson R. A. The catastrophic antiphospholipid syndrome // J. Rheumatol. — 1992. — Vol. 19. — P. 508–512.
  10. Asherson R. A., Shoenfeld Y. The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome — molecular mimicry? // J. Rheumatol. — 2000. — Vol. 27. — P. 12–14.
  11. Bashiri A., Burstein E., Mazor M. Cerebral palsy and fetal inflammatory response syndrome: a review // J. Perinat. Med. — 2006. — Vol. 34, N 1. — P. 5–12.
  12. Catastrophic Antiphospholipid Syndrome Registry Project Group. Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome / Cervera R. [et al.] // Ann. Rheum. Dis. — 2005. — Vol. 64. — P. 1205–1209.
  13. Catastrophic Antiphospholipid Syndrome Registry Project Group. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines / Asherson R. A. [et al.] // Lupus. — 2003. — Vol. 12. — P. 530–534.
  14. Cate H. Pathophysiology of disseminated intravascular coagulation in sepsis // Crit. Care Med. — 2000. — Vol. 28. — P. 9–11.
  15. Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients / Asherson R. A. [et al.] // Ann. Rheum. Dis. — 2005. — Vol. 64. — P. 943–946.
  16. Fetal thrombophilia and obstetrics complications / Makatsariya A. [et al.] // Pathophysiology of haemostasis and thrombosis: proceeding and abstracts from the 19th International Congress on Thrombosis. — Tel-Aviv, Israel, 2006. — P. A10.
  17. Gharavi A. E., Pierangeli S. S., Harris E. N. New developments in viral peptides and APL induction // J. Autoimmun. — 2000. — Vol. 15. — P. 227–230.
  18. Groot de P. G., Horbach D. A., Derksen R. H. Protein C and other cofactors involved in the binding of antiphospholipid antibodies: relation to the pathogenesis of thrombosis // Lupus. — 1996. — Vol. 5. — P. 488–493.
  19. Haemotology. Clinical cases uncovered / Shaun McCann [et al.]. — N-Y.: Wiley-Blackwell. A John Wiley & Sons, Ltd., 2009. — 190 p.
  20. Hemostasis and Thrombosis in obstetrics and gynecology / M. J. Paidas [et al.]. — Lockwood: Willey-Blackwell, 2011. — 223 p.
  21. High prevalence of antiphospholipid antibodies in disseminated intravascular coagulation / Karmochkine M. [et al.] // Thromb. Haemost. — 1996. — Vol. 75. — P. 971.
  22. Identification of polyclonal and monoclonal antibodies against tissue plasminogen activator in the antiphospholipid syndrome / Lu C. S. [et al.] // Arthritis Rheum. — 2005. — Vol. 52. — P. 4018–4027.
  23. Impaired factor XIIa-dependent activation of fibrinolysis in treated antiphospholipid syndrome gestations developing late-pregnancy complications / Carmona F. [et al.] // Am. J. Obstet. Gynecol. — 2006. — Vol. 194. — P. 457–465.
  24. Induction of antiphospholipid syndrome in Factor V Leiden mice / Katzav A. [et al.] // Immunobiology. — 2005. — Vol. 209. — P. 10–11.
  25. Kitchens C. S. Thrombotic storm: when thrombosis begets thrombosis // Am. J. Med. — 1998. — Vol. 104. — P. 381–385.
  26. Lai S., Walker D. H., Elghetany M. T. Catastrophic antiphospholipid syndrome: a rare cause of disseminated microvascular thrombotic injury — a case report with pathological and molecular correlative studies // Pathol. Int. — 2005. — Vol. 55. — P. 144–149.
  27. LIVE-ENOX Investigators. Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study / Brenner B. [et al.] // J. Thromb. Haemost. — 2005. — Vol.3. — P. 227–229.
  28. Makatsariya A., Asherson R. A., Bitsadze V. Catastrophic antiphospholipid (Asherson's) syndrome and genetic thrombophilic disorders in obstetrics / [et al.] // Autoimmun Rev. — 2006. — Vol. 6, N 2. — P. 89–93.
  29. Nelson S. M., Greer I. A. The potential role of heparin in assisted conception // Human Reproduction Update. — 2008. — Vol. 14, N 6. — P. 623–645.
  30. Perioperative medical management of antiphospholipid syndrome: hospital for special surgery experience, review of literature, and recommendations / Erkan D. [et al.] // J. Rheumatol. — 2002. — Vol. 29, N 4. — P. 843–849.
  31. Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombine ant human activated protein C for severe sepsis / Bernard G. R. [et al.] // N. Engl. J. Med. — 2001. — Vol. 344, N 10. — P. 699–709.
  32. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies / Raschi E. [et al.] // Blood. — 2003. — Vol. 101. — P. 3495–3500.
  33. Shoenfeld Y. The infectious etiology of APS: Novel cross reactive epitopes on yeasts, bacteria and viruses // Immunobiology. — 2005. — Vol. 209, suppl. 1.
  34. Significance of valine/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant / Yasuda S. [et al.] // Arthritis Rheum. — 2005. — Vol. 52, N 1. — P. 212–218.
  35. The Catastrophic Antiphospholipid Syndrome (Asherson's Syndrome). — N-Y.: Monograph. Collected papers, 2005. — 112 p.
  36. The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women / Le Thi Thuong D. [et al.] // Ann. Rheum. Dis. — 2005. — Vol. 64. — P. 273–278.
  37. Vora S. K., Asherson R. A., Erkan D. Catastrophic antiphospholipid syndrome // J. Intensive. Care Med. — 2006. — Vol. 21. — P. 144–159.

Copyright (c) 2012 Makatsariya A.D., Bitsadze V.O., Khizroeva D.K.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies